EGFL7 Antikörper (AA 24-100)
Kurzübersicht für EGFL7 Antikörper (AA 24-100) (ABIN7266907)
Target
Alle EGFL7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 24-100
-
Verwendungszweck
- EGFL7 Rabbit pAb
-
Sequenz
- YRPGRRVCAV RAHGDPVSES FVQRVYQPFL TTCDGHRACS TYRTIYRTAY RRSPGLAPAR PRYACCPGWK RTSGLPG
-
Kreuzreaktivität
- Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 24-100 of human EGFL7 (NP_958854.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
-
Andere Bezeichnung
- EGFL7
-
Hintergrund
- This gene encodes a secreted endothelial cell protein that contains two epidermal growth factor-like domains. The encoded protein may play a role in regulating vasculogenesis. This protein may be involved in the growth and proliferation of tumor cells. Alternate splicing results in multiple transcript variants.,EGFL7,NEU1,VE-STATIN,ZNEU1,Endocrine & Metabolism,Endocrine and metabolic diseases,Obesity,Cardiovascular,EGFL7
-
Molekulargewicht
- 29kDa
-
Gen-ID
- 51162
-
UniProt
- Q9UHF1
Target
-